Medical geneticist at Cedars-Sinai awarded $8.5 million NIH research grant

August 18, 2003

LOS ANGELES, August 18, 2003 - Medical geneticist and scientist, Jerome I. Rotter, M.D., has received an $8.5 million grant to further his search for the genes that contribute to heart disease in Mexican-American, African American, and Chinese populations within the U.S. Heart disease is the leading cause of death worldwide and the largest killer in the United States.

Dr. Rotter, Director of the Division of Medical Genetics and Director of the Common Disease Genetics Program at Cedars-Sinai, and his colleagues Drs. Leslie Raffel, Kent Taylor, and Xiuging Guo will receive about $1.7 million annually over a five-year period from the National Institutes of Health (NIH). The study will take place at 11 centers throughout the country.

The NIH grant will provide funding for the "MESA Family Study," an ancillary study to the Multi-Ethnic Study of Atherosclerosis, or MESA study (CSMC IRB No. 4174-01). MESA itself is a 10-year study of 6,800 people in four major U.S. ethnic groups to evaluate the origins of heart disease and to identify risk factors in multi-ethnic populations. The MESA Family study, under Dr. Rotter's leadership, builds on the existing MESA research by determining how genes contribute to coronary calcium in African-American and Hispanic American families and in Chinese Americans. Coronary calcium is a marker of the fatty plaque deposits that build-up in the arteries and can block blood-flow to the heart. Because coronary calcium builds up over time, symptoms do not usually appear until a person experiences chest pain or has a heart attack.

"In essence, our study serves as the genetic arm of the MESA study, as MESA evaluates the early natural history of coronary artery disease, while in the MESA Family study we aim to find the genes that contribute to this coronary artery disease," commented Dr. Rotter. "What we learn will eventually help us to identify people at the highest risk of developing heart disease so that we can ultimately prevent cardiac events such as heart attack and stroke from occurring."

While the parent MESA Study includes Caucasian, African-American, Hispanic American, and Chinese American subjects, the MESA Family Study was chosen by the NIH to emphasize non-majority populations in large part because much less is known regarding the genetics of coronary artery disease and its history in these ethnic groups.

Dr. Rotter and his research team have a long history of studying the genetic causes of common complex diseases, including heart disease, diabetes, and Crohn's Disease, an inflammatory disease affecting the gastrointestinal tract. Specifically, Dr. Rotter and his colleagues' research has resulted in identifying some of the genetic factors predisposing individuals to high blood pressure, high lipids and adult onset diabetes, all of which are major risk factors for developing heart disease. Further, Dr. Rotter's group identified a major genetic marker associated with Crohn's Disease in people of Ashkenazi Jewish descent.

In the MESA Family Study, the researchers will evaluate 1,800 siblings from 900 index individuals with coronary calcium as identified in the existing MESA study. The researchers will then determine the extent that genes contribute to the variation in coronary calcium between the two groups by utilizing highly specialized gene mapping techniques. The study will be conducted at various centers throughout the country that are designated to collect and analyze data, including laboratories at Cedars-Sinai Medical Center. In addition to Cedars-Sinai Medical Center, centers involved in the MESA Family Study are: Wake Forest University School of Medicine; Columbia University; Johns Hopkins University; University of Minnesota; Northwestern University Medical School; the University of Vermont; New England Medical Center, Harbor-UCLA Medical Center; the UCLA School of Medicine; and the University of Washington.

"Identifying the genes predisposing to coronary artery disease, will allow us to target screening and therapeutic interventions for patients who could benefit from specific prevention approaches," said David L. Rimoin, M.D., Chairman, Department of Pediatrics and the Director of the Medical Genetics-Birth Defects Center at Cedars-Sinai.

Cedars-Sinai Medical Center

Related Heart Disease Articles from Brightsurf:

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.

Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.

Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.

New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.

Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.

Heart failure: The Alzheimer's disease of the heart?
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.

Read More: Heart Disease News and Heart Disease Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to